A recent study employing Australian and UK type 1 diabetes families has demonstrated significant transmission bias to affected offspring of a polymorphism (1188A allele; termed allele 1) in the 3 0 untranslated region (3 0 UTR) of the interleukin 12B (IL12B) gene which encodes the IL-12p40 subunit of the pro-inflammatory cytokine IL-12. However, results from replication studies in other populations have been controversial. We performed both case-control (n ¼ 120 cases; n ¼ 330 controls) and familybased (n ¼ 307 families) association studies, using the transmission disequilibrium test, to investigate if allele 1 is associated with early-onset type 1 diabetes in Northern Ireland. No association was observed between allele 1 and type 1 diabetes in either case-control (80.8% vs 80.8%; P ¼ 0.98) or family-based (49.7% transmissions; P ¼ 0.94) studies. Our results do not support earlier reports of an association between allele 1 in the 3 0 UTR of the IL12B gene and type 1 diabetes.
Type 1 (insulin-dependent) diabetes mellitus is caused by the selective autoimmune destruction of the insulin producing b cells of the pancreas. 1 Destruction of b cells occurs in genetically predisposed individuals exposed to an unknown environmental trigger, and is effected by the actions of cytotoxic T cells and macrophages that are regulated by Th1 cells.
The HLA (IDDM1) 2 and insulin (IDDM2) 3 gene regions have been identified as susceptibility loci for type 1 diabetes. Furthermore, the CTLA4 (IDDM12) gene 4, 5 has been reported to be linked and associated with type 1 diabetes, and genome-wide linkage screens 6, 7 suggest that several other non-HLA genes remain to be identified. Recently, Morahan and co-workers screened a region of chromosome 5q33-34 in 249 type 1 diabetes families and found evidence for linkage in HLAmatched, but not HLA-mismatched, sib-pairs. 8 The linked region (designated IDDM18) lies near the interleukin 12B (IL12B) gene, which is a potential candidate gene for type 1 diabetes. Transmission disequilibrium test (TDT) 9 analysis revealed preferential transmission in Australian and UK families of the 1188A allele (termed allele 1 in the present report) of a single nucleotide polymorphism (1188A4C) in the 3 0 UTR of the IL12B gene. 8, 10 Furthermore, the association between allele 1 and type 1 diabetes was replicated in an independent cohort of Australian families. 11 Th1 cells in turn produce IL-2, TNF-b and IFN-g (which stimulates IL-12 production via a positive feedback loop). There is experimental evidence in vivo to support a role for IL-12 in the development of type 1 diabetes. In non-obese diabetic (NOD) mice administration of IL-12 can accelerate development of diabetes, 12 while antagonists to IL-12 protect NOD mice from diabetes. 13 Also, in vitro studies have demonstrated that high-risk first-degree relatives produce significantly higher levels of IL-12 compared to age-and sex-matched controls. 14 In the present study we have investigated if the 3 0 UTR polymorphism in the IL12B gene is associated with early-onset type 1 diabetes in the Northern Ireland population employing both case-control and familybased association studies involving a total of 120 cases, 330 healthy controls, and 307 trio families comprising both parents and an affected offspring. The probands were Caucasian and derived from a population-based register of individuals with type 1 diabetes diagnosed before their 15th birthday. 15 Controls comprised unrelated healthy children aged 12-15 years who were selected from a random sample of Northern Ireland schools. The distributions of genotypes in cases and controls were in Hardy-Weinberg equilibrium. Genotype and allele frequencies were virtually identical in cases compared to controls (Table 1 ). In addition, a comparison of total probands (n ¼ 427) vs controls revealed no significant difference in allele frequency between groups (79.9% vs 80.8% respectively for allele 1). Analysis of allele transmissions from heterozygous parents to probands revealed no significant distortion from the expected 50:50 transmission of alleles in total informative families (49.7% transmission for allele 1; Table 2 ). Since the Australian study provided evidence for linkage in HLAidentical sib-pairs but not HLA-mismatched sib-pairs, we stratified our data according to the HLA-DR type of the proband, but again found no significant distortion in allele transmissions for the 3 0 UTR polymorphism (Table 2 ). There was, however, a non-significant increase in transmission of allele 1 (62.7%; P ¼ 0.07) to probands positive for HLA-DR4 (not including DR3,4) ( Table 2 ). In addition, since we have previously demonstrated the utility of extreme phenotypes for linkage disequilibrium mapping in family-based association studies, 5 we stratified the family data into two groups (o5 and X5 years of age) according to age-at-onset of the proband; no association, however, was observed between allele 1 and type 1 diabetes in either age-group (Table 2) .
Morahan 16 In contrast, however, we found no evidence of association between allele 1 and type 1 diabetes in Northern Ireland, even after stratification of data according to HLA-DR type and age-at-onset of diabetes. It is noteworthy that Morahan et al 8 did not stratify their TDT data to assess genetic interaction with HLA status of probands.
Our findings agree with a recent extremely large study by Dahlman et al 17 who also failed to demonstrate association between allele 1 in the 3 0 UTR of the IL12B gene and type 1 diabetes employing 2873 diabetes families derived from the UK, US, Finland, Romania and Sardinia (50.7% transmissions, P ¼ 0.25). Sub-group analyses of their data according to HLA type, sex of affected sibling, parent-of-origin and age-at-onset also revealed no significant distortion in allele transmission. 17 Further support for a lack of association between allele 1 and type 1 diabetes is provided by a family-based study employing 387 Norwegian diabetes families (52.8% transmissions, P ¼ 0.40), 18 as well as an Italian casecontrol study. 19 It would appear that the most likely explanation for discrepancies in results between the different studies is that the initial positive findings of Morahan et al 8 and the Danish replication study 16 which was only marginally significant, are type 1 errors (i.e. false positives). The study by Dahlman et al 17 clearly demonstrates the utility of large data sets for association studies in type 1 diabetes if positive (or negative) findings are to be reliable. Although Morahan et al 8 reported an overall P value of 3.5 Â 10 À7 for allele 1, as pointed out by Dahlman et al, 17 this value is incorrect because it was obtained from the product of two separate P values. We believe that the findings of the present study are not due to type 2 errors for the following reasons. Taking an allele frequency of 80% as reference, our study was sufficiently large to have 95% power to detect as statistically significant (Po0.05; two-tailed) a difference in allele frequencies in cases (n ¼ 240 alleles) vs controls (n ¼ 660 alleles) of magnitude 90% vs 80%. Also, we observed no association between allele 1 and type 1 diabetes both in case-control and family-based studies, and allele frequencies in the present study (80.8%) were similar to those reported by the Australian group (79%). 8 Importantly, our results are consistent with similar association studies involving allele 1 and type 1 diabetes in a total of seven different populations. [17] [18] [19] Of interest, other casecontrol studies have found no association between the 3 0 UTR alleles in the IL12B gene and other autoimmune diseases. 17, 20, 21 Morahan et al 8 also reported IL-12p40 expression in 1,1 homozygote cell lines to be significantly higher relative to 2,2 homozygote cell lines, although it is important to note that this observation was based on assessment of only two cell lines. The authors indicate that the relation between these allelic variants and expression levels may explain the association of allele 1 with type 1 diabetes. The nature of this relation, however, is unclear and the authors suggest that it is unlikely to be due to differences in mRNA stability. In contrast, Dahlman et al 17 utilising a total of 19 different cell lines found no significant correlation between any of the three possible genotypes and IL-12p40 expression levels. Note: Genotyping for the 3 0 UTR polymorphism (1188A4C) was performed on DNA samples employing PCR-restriction fragment length polymorphism typing using the restriction enzyme Taq I and previously described primers. 10 Allele 1 (uncut) was assigned based on the presence a 300 bp fragment, and allele 2 (cut) based on 161 and 139 bp fragments. Genotype and allele frequencies in the groups were compared using the w 2 test for 2 Â 3 and 2 Â 2 contingency tables respectively, and the level of significance was set at 5%.
In conclusion, the results of the present study are in agreement with a recent report by Dahlman et al 17 and support the view that the initial positive findings of Morahan et al 8 are most likely due to a type 1 error. Nevertheless, further investigation of novel single nucleotide polymorphisms in the IL12B and IL12A genes should be pursued to assess if genetic variation in the subunits of IL-12 contributes to type 1 diabetes.
